IRIS-Coroflex NEO Cohort

NCT06177743 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-06-11

No results posted yet for this study

Summary

The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.

Conditions

Interventions

DEVICE

Coroflex ISAR NEO stent

Percutaneous coronary intervention with Coroflex ISAR NEO stent

Sponsors & Collaborators

  • The CardioVascular Research Foundation (CVRF)

    collaborator UNKNOWN
  • Seung-Jung Park

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-09
Primary Completion
2026-12-31
Completion
2030-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06177743 on ClinicalTrials.gov